Does the media prefer CHE or WST?

In the previous week, Chemed had 11 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 22 mentions for Chemed and 11 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.52 beat Chemed's score of 0.74 indicating that West Pharmaceutical Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemed 7 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive West Pharmaceutical Services 11 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer EHC or WST?

In the previous week, Encompass Health and Encompass Health both had 11 articles in the media. West Pharmaceutical Services' average media sentiment score of 1.52 beat Encompass Health's score of 1.40 indicating that West Pharmaceutical Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Encompass Health 8 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive West Pharmaceutical Services 11 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media refer more to COO or WST?

In the previous week, Cooper Companies had 7 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 18 mentions for Cooper Companies and 11 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.52 beat Cooper Companies' score of 0.89 indicating that West Pharmaceutical Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 11 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive West Pharmaceutical Services 11 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer ALGN or WST?

In the previous week, Align Technology had 19 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 30 mentions for Align Technology and 11 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.52 beat Align Technology's score of 0.79 indicating that West Pharmaceutical Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 12 Very Positive mention(s) 4 Positive mention(s) 9 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive West Pharmaceutical Services 11 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor WST or MMSI?

In the previous week, Merit Medical Systems had 25 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 36 mentions for Merit Medical Systems and 11 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.52 beat Merit Medical Systems' score of 1.22 indicating that West Pharmaceutical Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment West Pharmaceutical Services 11 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Merit Medical Systems 19 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

West Pharmaceutical Services (WST) Competitors

$341.04 +0.08 (+0.02%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$341.51 +0.47 (+0.14%)

As of 07/31/2026 07:34 PM Eastern

Compare

WST vs. CHE, EHC, COO, ALGN, and MMSI

Should you buy West Pharmaceutical Services stock or one of its competitors? MarketBeat compares West Pharmaceutical Services with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with West Pharmaceutical Services include Chemed (CHE), Encompass Health (EHC), Cooper Companies (COO), Align Technology (ALGN), and Merit Medical Systems (MMSI).

How does West Pharmaceutical Services compare to Chemed?

Chemed (NYSE:CHE) and West Pharmaceutical Services (NYSE:WST) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, media sentiment, profitability, risk and earnings.

West Pharmaceutical Services has a net margin of 16.98% compared to Chemed's net margin of 10.60%. Chemed's return on equity of 31.77% beat West Pharmaceutical Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	10.60%	31.77%	18.90%
West Pharmaceutical Services	16.98%	20.11%	14.83%

95.9% of Chemed shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 3.3% of Chemed shares are held by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Chemed presently has a consensus target price of $530.75, indicating a potential downside of 0.43%. West Pharmaceutical Services has a consensus target price of $364.42, indicating a potential upside of 6.85%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, analysts clearly believe West Pharmaceutical Services is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00

In the previous week, Chemed had 11 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 22 mentions for Chemed and 11 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.52 beat Chemed's score of 0.74 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemed	7 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
West Pharmaceutical Services	11 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

West Pharmaceutical Services has higher revenue and earnings than Chemed. Chemed is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.53B	2.80	$265.24M	$19.91	26.77
West Pharmaceutical Services	$3.07B	7.81	$493.70M	$7.81	43.67

Chemed pays an annual dividend of $2.40 per share and has a dividend yield of 0.5%. West Pharmaceutical Services pays an annual dividend of $0.88 per share and has a dividend yield of 0.3%. Chemed pays out 12.1% of its earnings in the form of a dividend. West Pharmaceutical Services pays out 11.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemed has raised its dividend for 16 consecutive years. Chemed is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Chemed has a beta of 0.51, suggesting that its share price is 49% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market.

Summary

West Pharmaceutical Services beats Chemed on 12 of the 20 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Encompass Health?

Encompass Health (NYSE:EHC) and West Pharmaceutical Services (NYSE:WST) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

Encompass Health has higher revenue and earnings than West Pharmaceutical Services. Encompass Health is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Encompass Health	$5.94B	1.86	$566.20M	$5.99	18.58
West Pharmaceutical Services	$3.07B	7.81	$493.70M	$7.81	43.67

In the previous week, Encompass Health and Encompass Health both had 11 articles in the media. West Pharmaceutical Services' average media sentiment score of 1.52 beat Encompass Health's score of 1.40 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Encompass Health	8 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
West Pharmaceutical Services	11 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

97.3% of Encompass Health shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 1.8% of Encompass Health shares are held by company insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Encompass Health presently has a consensus target price of $143.86, suggesting a potential upside of 29.28%. West Pharmaceutical Services has a consensus target price of $364.42, suggesting a potential upside of 6.85%. Given Encompass Health's higher probable upside, research analysts plainly believe Encompass Health is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Encompass Health	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.89
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00

Encompass Health pays an annual dividend of $0.76 per share and has a dividend yield of 0.7%. West Pharmaceutical Services pays an annual dividend of $0.88 per share and has a dividend yield of 0.3%. Encompass Health pays out 12.7% of its earnings in the form of a dividend. West Pharmaceutical Services pays out 11.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Encompass Health has raised its dividend for 2 consecutive years. Encompass Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Encompass Health has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.15, suggesting that its stock price is 15% more volatile than the broader market.

West Pharmaceutical Services has a net margin of 16.98% compared to Encompass Health's net margin of 10.04%. West Pharmaceutical Services' return on equity of 20.11% beat Encompass Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Encompass Health	10.04%	18.28%	8.27%
West Pharmaceutical Services	16.98%	20.11%	14.83%

Summary

West Pharmaceutical Services beats Encompass Health on 12 of the 19 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and West Pharmaceutical Services (NYSE:WST) are both large-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

Cooper Companies presently has a consensus target price of $81.36, suggesting a potential upside of 12.50%. West Pharmaceutical Services has a consensus target price of $364.42, suggesting a potential upside of 6.85%. Given Cooper Companies' higher possible upside, equities research analysts clearly believe Cooper Companies is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00

In the previous week, Cooper Companies had 7 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 18 mentions for Cooper Companies and 11 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.52 beat Cooper Companies' score of 0.89 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	11 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
West Pharmaceutical Services	11 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 2.1% of Cooper Companies shares are held by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

West Pharmaceutical Services has lower revenue, but higher earnings than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.09B	3.45	$374.90M	$1.18	61.29
West Pharmaceutical Services	$3.07B	7.81	$493.70M	$7.81	43.67

Cooper Companies has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.15, indicating that its stock price is 15% more volatile than the broader market.

West Pharmaceutical Services has a net margin of 16.98% compared to Cooper Companies' net margin of 5.57%. West Pharmaceutical Services' return on equity of 20.11% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	5.57%	10.88%	7.27%
West Pharmaceutical Services	16.98%	20.11%	14.83%

Summary

West Pharmaceutical Services beats Cooper Companies on 12 of the 17 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Align Technology?

Align Technology (NASDAQ:ALGN) and West Pharmaceutical Services (NYSE:WST) are both large-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, media sentiment, profitability and institutional ownership.

88.4% of Align Technology shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 0.8% of Align Technology shares are owned by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

West Pharmaceutical Services has lower revenue, but higher earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.03B	3.00	$410.35M	$5.75	29.42
West Pharmaceutical Services	$3.07B	7.81	$493.70M	$7.81	43.67

West Pharmaceutical Services has a net margin of 16.98% compared to Align Technology's net margin of 9.99%. West Pharmaceutical Services' return on equity of 20.11% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	9.99%	15.86%	10.32%
West Pharmaceutical Services	16.98%	20.11%	14.83%

In the previous week, Align Technology had 19 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 30 mentions for Align Technology and 11 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.52 beat Align Technology's score of 0.79 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	12 Very Positive mention(s)	4 Positive mention(s)	9 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
West Pharmaceutical Services	11 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Align Technology presently has a consensus target price of $206.36, indicating a potential upside of 21.99%. West Pharmaceutical Services has a consensus target price of $364.42, indicating a potential upside of 6.85%. Given Align Technology's higher probable upside, equities research analysts plainly believe Align Technology is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00

Align Technology has a beta of 1.65, meaning that its share price is 65% more volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.15, meaning that its share price is 15% more volatile than the broader market.

Summary

West Pharmaceutical Services beats Align Technology on 12 of the 17 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Merit Medical Systems?

West Pharmaceutical Services (NYSE:WST) and Merit Medical Systems (NASDAQ:MMSI) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

West Pharmaceutical Services has a net margin of 16.98% compared to Merit Medical Systems' net margin of 9.22%. West Pharmaceutical Services' return on equity of 20.11% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.98%	20.11%	14.83%
Merit Medical Systems	9.22%	13.75%	8.10%

In the previous week, Merit Medical Systems had 25 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 36 mentions for Merit Medical Systems and 11 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.52 beat Merit Medical Systems' score of 1.22 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
West Pharmaceutical Services	11 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Merit Medical Systems	19 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

West Pharmaceutical Services has higher revenue and earnings than Merit Medical Systems. Merit Medical Systems is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	7.81	$493.70M	$7.81	43.67
Merit Medical Systems	$1.52B	3.35	$128.49M	$2.42	35.13

West Pharmaceutical Services has a beta of 1.15, indicating that its share price is 15% more volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.48, indicating that its share price is 52% less volatile than the broader market.

West Pharmaceutical Services presently has a consensus target price of $364.42, suggesting a potential upside of 6.85%. Merit Medical Systems has a consensus target price of $100.30, suggesting a potential upside of 17.99%. Given Merit Medical Systems' higher probable upside, analysts clearly believe Merit Medical Systems is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

Summary

West Pharmaceutical Services beats Merit Medical Systems on 13 of the 17 factors compared between the two stocks.

Get West Pharmaceutical Services News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WST vs. The Competition

Export

Metric	West Pharmaceutical Services	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$24.00B	$5.58B	$6.86B	$23.67B
Dividend Yield	0.26%	1.79%	2.59%	4.22%
P/E Ratio	43.67	23.12	282.27	31.00
Price / Sales	7.81	56.66	563.88	19.22
Price / Cash	35.02	32.53	28.60	18.73
Price / Book	7.73	6.29	10.93	4.76
Net Income	$493.70M	$151.15M	$3.49B	$1.07B
7 Day Performance	2.87%	0.99%	-0.61%	-0.34%
1 Month Performance	-6.79%	4.41%	-3.75%	-0.53%
1 Year Performance	42.61%	2.34%	62.10%	19.19%

West Pharmaceutical Services Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WST West Pharmaceutical Services	4.2571 of 5 stars	$341.04 +0.0%	$364.42 +6.9%	+42.6%	$24.00B	$3.07B	43.67	10,800
CHE Chemed	3.5938 of 5 stars	$508.30 -0.6%	$480.25 -5.5%	+27.5%	$6.78B	$2.53B	27.70	15,811	Earnings Report Analyst Forecast
EHC Encompass Health	4.6665 of 5 stars	$113.77 +0.8%	$143.86 +26.4%	+2.4%	$11.20B	$5.94B	18.99	42,000	Positive News Upcoming Earnings
COO Cooper Companies	3.0562 of 5 stars	$70.29 0.0%	$81.85 +16.4%	+2.0%	$13.71B	$4.09B	59.57	15,000	Positive News
ALGN Align Technology	3.5496 of 5 stars	$168.05 +0.6%	$206.36 +22.8%	+23.9%	$11.96B	$4.03B	28.20	20,290	Trending News Earnings Report Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:WST) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

West Pharmaceutical Services (WST) Competitors

WST vs. CHE, EHC, COO, ALGN, and MMSI

How does West Pharmaceutical Services compare to Chemed?

Summary

How does West Pharmaceutical Services compare to Encompass Health?

Summary

How does West Pharmaceutical Services compare to Cooper Companies?

Summary

How does West Pharmaceutical Services compare to Align Technology?

Summary

How does West Pharmaceutical Services compare to Merit Medical Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WST vs. The Competition

West Pharmaceutical Services Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

West Pharmaceutical Services (WST) Competitors

WST vs. CHE, EHC, COO, ALGN, and MMSI

How does West Pharmaceutical Services compare to Chemed?

Is CHE or WST more profitable?

Do institutionals and insiders hold more shares of CHE or WST?

Do analysts prefer CHE or WST?

Does the media prefer CHE or WST?

Which has preferable valuation & earnings, CHE or WST?

Is CHE or WST a better dividend stock?

Which has more risk and volatility, CHE or WST?

Summary

How does West Pharmaceutical Services compare to Encompass Health?

Which has stronger earnings and valuation, EHC or WST?

Does the media prefer EHC or WST?

Do institutionals & insiders have more ownership in EHC or WST?

Do analysts recommend EHC or WST?

Is EHC or WST a better dividend stock?

Which has more risk & volatility, EHC or WST?

Is EHC or WST more profitable?

Summary

How does West Pharmaceutical Services compare to Cooper Companies?

Do analysts prefer COO or WST?

Does the media refer more to COO or WST?

Do institutionals & insiders hold more shares of COO or WST?

Which has preferable earnings and valuation, COO or WST?

Which has more risk and volatility, COO or WST?

Is COO or WST more profitable?

Summary

How does West Pharmaceutical Services compare to Align Technology?

Do institutionals & insiders believe in ALGN or WST?

Which has better earnings and valuation, ALGN or WST?

Is ALGN or WST more profitable?

Does the media prefer ALGN or WST?

Do analysts recommend ALGN or WST?

Which has more volatility and risk, ALGN or WST?

Summary

How does West Pharmaceutical Services compare to Merit Medical Systems?

Do insiders and institutionals have more ownership in WST or MMSI?

Is WST or MMSI more profitable?

Does the media favor WST or MMSI?

Which has higher valuation & earnings, WST or MMSI?

Which has more volatility & risk, WST or MMSI?

Do analysts prefer WST or MMSI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WST vs. The Competition

West Pharmaceutical Services Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools